Ponaxen 45mg (Ponatinib)

Description

About Ponaxen 45mg (Ponatinib)

This medication is prescribed to patients suffering from specific forms of chronic myeloid leukemia in order to treat their condition. It belongs to the category of tyrosine-kinase inhibitors that can block multiple targets at once. C29H27F3N6O IS ITS COMPLETE CHEMICAL FORMULA. The half-life of its elimination ranges somewhere between 12 and 66 hours. As a treatment for chronic myeloid leukemia, it is very effective against the T315I mutation. This medication is more commonly known by its generic name, ponatinib. Everest Pharma is the company that produces and distributes this particular medication.

Dosages 

When beginning treatment with Ponaxen 45mg, the recommended starting dosage is 45 mg taken orally once daily. You can take it either with the food or on an empty stomach. You must ensure that the entire pill goes down.

Side Effects 

• inflammation of the pancreas
• Bladder pain
• increased risk of stroke.
• dizziness
• heart problems.
• Fainting

Storage 

This must be stored between 20 and 25 °C (68 and 77 °F), with a maximum excursion temperature of 15 to 30 °C (59 to 86 °F). Do not expose this to moisture or direct sunlight.